IL1R1 and rheumatoid arthritis: In a transgenic mouse model of genetic CJD, antagonizing IL1R1 with anakinra (already used clinically to treat rheumatoid arthritis) normalized hippocampal neurotransmission and reduced seizure susceptibility [96], reinforcing that modulation of IL1R1 signaling or its expression could offer therapeutic benefits to TSEs [97].